LONDON: An alternative anti-coronavirus jab aimed at protecting those who cannot receive vaccines will enter major trials this weekend. The drug is made by AstraZeneca, the pharmaceutical company
Arabian Post strives to deliver the most accurate and reliable information to its readers. If you believe you have identified an error or inconsistency in this article, please don't hesitate to contact our editorial team at editor[at]thearabianpost[dot]com. We are committed to promptly addressing any concerns and ensuring the highest level of journalistic integrity.